Published Data Registry

show all
TitleAuthorsJournalPublication year
DOI
PMID
Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.(Open Access) Peters F, Salihoglu H, (...), Herms JThe EMBO journal2019
CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date.Ancau M, Berthele A, Hemmer BExpert opinion on biological therapy2019
Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion?(Open Access) Pongratz V, Schmidt P, (...), Mühlau MBrain and behavior2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.(Open Access) Pottier C, Ren Y, (...), Rademakers RActa neuropathologica2019
The Atherosclerosis Risk Variant rs2107595 Mediates Allele-Specific Transcriptional Regulation of HDAC9 via E2F3 and Rb1.(Open Access) Prestel M, Prell-Schicker C, (...), Dichgans MStroke2019
[Leber's Hereditary Optic Neuropathy].Priglinger C, Klopstock T, Rudolph G, Priglinger SGKlinische Monatsblatter fur Augenheilkunde2019
Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity.Höllerhage M, Bickle M, Höglinger GUCurrent neurology and neuroscience reports2019
Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction.(Open Access) Raabe FJ, Slapakova L, (...), Schmitt ACells2019
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA).(Open Access) Reetz K, Hilgers RD, (...), Schulz JBNeurological research and practice2019
Fibril-induced glutamine-/asparagine-rich prions recruit stress granule proteins in mammalian cells.(Open Access) Riemschoss K, Arndt V, (...), Vorberg IMLife science alliance2019